Silke Walter

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Role of the Toll-Like Receptor 4 in Neuroinflammation in Alzheimer’s Disease

Silke Walter, Maryse Letièmbre, Yang Liu et al. · Cellular Physiology and Biochemistry · 2007 · 511 citations

Tlr4 Mrna, Innate Immune System, Immunology +18

Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial

Silke Walter, Panagiotis Kostopoulos, Isabel Keller et al. · The Lancet Neurology · 2012 · 484 citations

Thrombosis, Stroke Rehabilitation, Cardiovascular Disease +12

LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide

Yang Liu, Silke Walter, Massimiliano Stagi et al. · Brain · 2005 · 345 citations · Full text

The LPS receptor (CD14) links innate immunity with Alzheimer's disease

Silke Walter, Sandra Kühl, R. Landmann et al. · The FASEB Journal · 2003 · 307 citations · Full text

Lps Receptor, Microbial Pathogens, Innate Immune System +16